Avidity Biosciences (RNA) Short Interest Ratio & Short Volume → The only AI company you should be looking at (From Behind the Markets) (Ad) Free RNA Stock Alerts $26.45 +0.87 (+3.40%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial Media Avidity Biosciences Short Interest DataCurrent Short Volume10,660,000 sharesPrevious Short Volume9,980,000 sharesChange Vs. Previous Month+6.81%Dollar Volume Sold Short$254.88 millionShort Interest Ratio / Days to Cover9.0Last Record DateApril 15, 2024Outstanding Shares95,620,000 sharesPercentage of Shares Shorted11.15%Today's Trading Volume641,653 sharesAverage Trading Volume853,795 sharesToday's Volume Vs. Average75% Short Selling Avidity Biosciences ? Sign up to receive the latest short interest report for Avidity Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRNA Short Interest Over TimeRNA Days to Cover Over TimeRNA Percentage of Float Shorted Over Time Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details Avidity Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202410,660,000 shares $254.88 million +6.8%N/A9 $23.91 3/31/20249,980,000 shares $254.69 million +15.8%N/A8.2 $25.52 3/15/20248,620,000 shares $210.50 million +10.9%N/A7.3 $24.42 2/29/20247,770,000 shares $142.19 million +0.5%N/A6.5 $18.30 2/15/20247,730,000 shares $104.59 million +1.2%N/A5.4 $13.53 1/31/20247,640,000 shares $93.44 million +4.1%N/A5.4 $12.23 Get the Latest News and Ratings for RNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avidity Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20247,340,000 shares $83.31 million -25.3%N/A5.5 $11.35 12/31/20239,830,000 shares $88.96 million -8.0%N/A7.4 $9.05 12/15/202310,680,000 shares $92.38 million -3.2%N/A8.5 $8.65 11/30/202311,030,000 shares $86.14 million +1.5%N/A9 $7.81 11/15/202310,870,000 shares $67.72 million -6.3%N/A13.7 $6.23 10/31/202311,600,000 shares $59.74 million +0.3%N/A14.7 $5.15 10/15/202311,570,000 shares $71.50 million -25.3%N/A14.5 $6.18 9/30/202315,490,000 shares $98.83 million -7.4%N/A20.3 $6.38 9/15/202316,720,000 shares $117.21 million +2.1%N/A21.3 $7.01 8/31/202316,380,000 shares $123.83 million +2.0%N/A18.2 $7.56 8/15/202316,060,000 shares $139.40 million +2.8%N/A17.9 $8.68 7/31/202315,620,000 shares $148.55 million -2.7%N/A15.7 $9.51 7/15/202316,050,000 shares $173.82 million +2.2%N/A13.4 $10.83 6/30/202315,710,000 shares $174.22 million +11.4%N/A12 $11.09 6/15/202314,100,000 shares $175.97 million +5.2%N/A9.7 $12.48 5/31/202313,400,000 shares $142.31 million +4.4%N/A10.1 $10.62 5/15/202312,840,000 shares $144.45 million +29.3%N/A9.5 $11.25 4/30/20239,930,000 shares $123.13 million -12.4%N/A7.6 $12.40 4/15/202311,330,000 shares $169.72 million +3.9%N/A10.6 $14.98 3/31/202310,910,000 shares $167.47 million +25.6%N/A10.5 $15.35 3/15/20238,690,000 shares $184.05 million +4.6%N/A9.1 $21.18 2/28/20238,310,000 shares $196.95 million +5.5%N/A4.2 $23.70 2/15/20237,880,000 shares $194.64 million +5.1%N/A4.1 $24.70 1/31/20237,500,000 shares $177.75 million -4.7%N/A3.9 $23.70 1/15/20237,870,000 shares $178.26 million -5.0%N/A4.1 $22.65 12/30/20228,280,000 shares $183.73 million +27.2%N/A4.5 $22.19 12/15/20226,510,000 shares $118.16 million -7.3%N/A3.6 $18.15 11/30/20227,020,000 shares $81.71 million -0.1%N/A11.6 $11.64 11/15/20227,030,000 shares $100.53 million +26.7%N/A13.2 $14.30 10/31/20225,550,000 shares $79.25 million +12.6%N/A11.8 $14.28 10/15/20224,930,000 shares $80.90 million +7.4%N/A11.1 $16.41 9/30/20224,590,000 shares $74.95 million -13.4%N/A11.8 $16.33 9/15/20225,300,000 shares $112.36 million +0.8%N/A16.3 $21.20 8/31/20225,260,000 shares $103.20 million -5.6%N/A15.1 $19.62The asset beating inflation by 4x (Ad)"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details RNA Short Interest - Frequently Asked Questions What is Avidity Biosciences' current short interest? Short interest is the volume of Avidity Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 10,660,000 shares of RNA short. Learn More on Avidity Biosciences' current short interest. What is a good short interest ratio for Avidity Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RNA shares currently have a short interest ratio of 9.0. Learn More on Avidity Biosciences's short interest ratio. Is Avidity Biosciences' short interest increasing or decreasing? Avidity Biosciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 10,660,000 shares, an increase of 6.8% from the previous total of 9,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Avidity Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Avidity Biosciences: NewAmsterdam Pharma (0.85%), Rocket Pharmaceuticals, Inc. (12.12%), Galapagos NV (2.30%), Amneal Pharmaceuticals, Inc. (2.51%), Evotec SE (0.02%), Structure Therapeutics Inc. (9.92%), Amphastar Pharmaceuticals, Inc. (11.01%), Agios Pharmaceuticals, Inc. (12.15%), Keros Therapeutics, Inc. (6.27%), Syndax Pharmaceuticals, Inc. (11.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Avidity Biosciences stock? Short selling RNA is an investing strategy that aims to generate trading profit from Avidity Biosciences as its price is falling. RNA shares are trading up $0.87 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Avidity Biosciences? A short squeeze for Avidity Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RNA, which in turn drives the price of the stock up even further. How often is Avidity Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NewAmsterdam Pharma Short Squeeze Rocket Pharmaceuticals Short Squeeze Galapagos Short Squeeze Amneal Pharmaceuticals Short Squeeze Evotec Short Squeeze Structure Therapeutics Short Squeeze Amphastar Pharmaceuticals Short Squeeze Agios Pharmaceuticals Short Squeeze Keros Therapeutics Short Squeeze Syndax Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RNA) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the Markets